Table 2 Demographic, clinical and serological data of the SCIT-treated study group and the control cohort - with allergy to Poaceae.
Characteristics | Study group treated by SCIT with Poaceae (n = 19) | Control group without SCIT with Poaceae (n = 15) |
|---|---|---|
Gender | ||
Male | 15 (79%) | 8 (53%) |
Female | 4 (21%) | 7 (47%) |
Age (yrs) | 29 (range: 7–66) | 31 (range: 7–57) |
Children (<12 years old) | 2 (11%) | 1 (7%) |
Number of allergen sources sensitized to | 3.7 | 2.9 |
Most common co-sensitization against | ||
Fagales | 14 (74%) | 8 (53%) |
House dust mite | 9 (47%) | 6 (40%) |
Cat | 5 (26%) | 4 (27%) |
Oleaceae | 4 (21%) | 3 (20%) |
OAS related to various allergen sources | 7 (37%) | 6 (40%) |
Asthmatic complaints | 5 (26%) | 5 (33%) |
Atopic dermatitis | 2 (11%) | 2 (13%) |
Total serum IgE [kU/l] | 196 (range: 13–1978) | 238 (range: 35–726) |
Prevalence of sIgE, prior to therapy, against | ||
Phl p 1 | 17 (89%) | 14 (93%) |
Phl p 2 | 8 (42%) | 3 (20%) |
Phl p 5b | 10 (53%) | 9 (60%) |
Phl p 6 | 7 (37%) | 7 (47%) |
Phl p 7 | 1 (5%) | 0 (0%) |
Phl p 12 | 1 (5%) | 2 (13%) |
